Breakthrough Kidney Cancer Research Aims to Transform Diagnosis & Treatment Madelyn OlsenMarch 19, 2025Grant Announcement
New Hope for Hereditary Kidney Cancer: PHASE ONE Funds Pioneering Study for HLRCC Madelyn OlsenFebruary 12, 2025Grant Announcement
Revolutionizing Treatment for Rare Head and Neck Cancer: PHASE ONE Funds Breakthrough Study for NOTCH-Activated Adenoid Cystic Carcinoma Madelyn OlsenDecember 13, 2024Grant Announcement
Breakthrough Turmeric Clinical Trial: PHASE ONE Grant Fuels Hope for Less Toxic Oral Cancer Treatment Madelyn OlsenSeptember 11, 2024Grant Announcement
Breaking Barriers: PHASE ONE Funds Promising Immunotherapy Research for Metastatic Pancreatic Cancer Madelyn OlsenJune 13, 2024Grant Announcement
Promising New Combination Therapy May Pave the Way for Targeted Treatment in Non-Hodgkin Lymphoma Madelyn OlsenApril 17, 2024Grant Announcement
Revolutionizing T-cell Acute Lymphoblastic Leukemia (T-ALL) Treatment: A Novel Combination Therapy Offers New Hope Madelyn OlsenDecember 12, 2023Grant Announcement
Unlocking New Hope: PHASE ONE Funds Phase I/II Trial Investigating a Novel Approach to Pediatric Cancer Treatment for Solid Tumors Madelyn OlsenSeptember 19, 2023Grant Announcement
PHASE ONE Funds Phase II Trial Using Biomarkers to Match Metastatic ER+ Breast Cancer Patients with Effective Treatments Madelyn OlsenJuly 27, 2023Grant Announcement
